摘要:
After a PhD in neuropharmacology in 2010, at Sygnis Bioscience (Heidelberg, Germany), he joined as a junior scientist the laboratory headed by Jean Philippe Loeffler in Strasbourg (France), to characterize new pathological mechanisms of amytrophic lateral sclerosis, a devastating neuodegenerative disease afflicting the motor system.He is currently funded by an european program to identify the pathological signatures in the transcriptom of patients and the crosstalk between lipids and maintenance of the neuromuscular axis integrity.INSERM U1118Central and peripheral mechanisms of Neurodegeneration
展开